The efficacy of radiation therapy using the Quad Shot regimen in cutaneous metastasis from parotid gland cancer: A case report-Reference-Cited by-同舟云学术

The efficacy of radiation therapy using the Quad Shot regimen in cutaneous metastasis from parotid gland cancer: A case report

Published:2023-07 Issue:7 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Okada Kohei¹^ORCID,Takahashi Satoru¹,Endo Masashi¹,Fukuda Yukiko¹,Ogawa Kazunari¹,Kawahara Masahiro²,Akahane Keiko²,Nishino Hiroshi³,Yamaguchi Hironori⁴,Shirai Katsuyuki¹^ORCID

Affiliation:

1. Department of Radiology Jichi Medical University Hospital Tochigi Japan

2. Department of Radiology Jichi Medical University Saitama Medical Center Saitama Japan

3. Department of Otolaryngology Jichi Medical University Hospital Tochigi Japan

4. Department of Medical Oncology Jichi Medical University Hospital Tochigi Japan

Abstract

Key Clinical MessageCutaneous metastasis from malignant tumors can cause symptoms such as exudates, bleeding, and pain, which remarkably reduce patient's quality of life. Herein, we report a case in which radiation therapy using the Quad Shot regimen was effective in the treatment of cutaneous metastasis from parotid gland cancer.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7687

Reference15 articles.

1. The presentation, pathology, and current management strategies of cutaneous metastasis

2. Efficacy of Skin-Directed Therapy for Cutaneous Metastases From Advanced Cancer: A Meta-Analysis

3. Unresectable cutaneous metastatic tumor in the arm that underwent complete remission after radiotherapy

4. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers

5. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin/fluorouracil/pembrolizumab;Reactions Weekly;2023-10-21